Quest Diagnostics Inc. (DGX)

102.56
0.10 0.10
NYSE : Health Services
Prev Close 102.66
Open 102.83
Day Low/High 102.00 / 103.00
52 Wk Low/High 78.95 / 107.97
Volume 782.17K
Avg Volume 928.20K
Exchange NYSE
Shares Outstanding 134.67M
Market Cap 14.10B
EPS 5.40
P/E Ratio 20.30
Div & Yield 2.12 (1.99%)
7 Dividend Stocks Shoveling Cash to Shareholders

7 Dividend Stocks Shoveling Cash to Shareholders

These companies recently increased their dividend payouts to shareholders.

Analysts' Actions: AMZN, NFLX, CMI, X, PNRA

Analysts' Actions: AMZN, NFLX, CMI, X, PNRA

Here are today's top research calls.

Analyst Actions -- 10/26/2011

Here are today's top research calls.

Quest Diagnostics Inc (DGX): Today's Featured Health Services Winner

Quest Diagnostics Inc (DGX): Today's Featured Health Services Winner

Quest Diagnostics Inc was a winner within the health services industry, rising $5.52 (10.8%) to $56.50 on heavy volume.

Quest Diagnostics' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Quest Rises On Unusually High Volume (DGX)

Quest Rises On Unusually High Volume (DGX)

Quest Diagnostics Inc (NYSE:DGX) is trading at unusually high volume Tuesday with 7.6 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up $5.61 (+11%).

Analysts' Actions: S, SYK, MCD, NFLX, GIS

Analysts' Actions: S, SYK, MCD, NFLX, GIS

Here are today's top research calls.

Analyst Actions -- 10/11/2011

Here are today's top research calls.

Quest Stock To Go Ex-dividend Tomorrow (DGX)

Quest Stock To Go Ex-dividend Tomorrow (DGX)

The ex-dividend date for Quest Diagnostics Inc (NYSE:DGX) is tomorrow, October 5, 2011. Owners of shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $45.85 as of 9:30 a.m., the dividend yield is 0.8%.

Analyst Actions -- 9/23/2011

Here are today's top research calls.

Analysts' Actions: HPQ, FDX, FSLR, NKE, CBS

Analysts' Actions: HPQ, FDX, FSLR, NKE, CBS

Here are today's top research calls.

Quest Diagnostics' CEO Discusses Q2 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q2 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q2 2011 Results - Earnings Call Transcript

AutoNation, Quest: Analysts' New Ratings

AutoNation, Quest: Analysts' New Ratings

AutoNation downgraded at Wells from Market Perform to Underperform. Quest Diagnostics downgraded at Jefferies from Buy to Hold.

Cramer's 'Mad Money' Recap: Don't Pin Rally on Bernanke (Final)

Cramer's 'Mad Money' Recap: Don't Pin Rally on Bernanke (Final)

Cramer said other factors, including good news from China and Japan and the lack of news from Europe, played a bigger role in today's rally.

'Mad Money Lightning Round': Go for Southern Company

'Mad Money Lightning Round': Go for Southern Company

Cramer likes the stock and tells viewers it would be a good addition to a diversified portfolio.

News Corp., Google: Analysts' New Ratings

News Corp., Google: Analysts' New Ratings

Google rated new Overweight at JPMorgan. News Corp. downgraded at Argus from Buy to Hold.

Kendall Law Group Investigates Quest Diagnostics Inc.

Kendall Law Group Investigates Quest Diagnostics Inc.

Kendall Law Group, a national securities firm led by a former federal judge with attorneys that include a former U.

Quest Stock To Go Ex-dividend Tomorrow (DGX)

Quest Stock To Go Ex-dividend Tomorrow (DGX)

The ex-dividend date for Quest Diagnostics (NYSE:DGX) is tomorrow, June 30, 2011. Owners of shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $59.21 as of 9:34 a.m., the dividend yield is 0.7%.

Quest Reaches New 52-Week High (DGX)

Quest Reaches New 52-Week High (DGX)

Quest Diagnostics (NYSE:DGX) hit a new 52-week high Thursday as it is currently trading at $59.77, above its previous 52-week high of $59.75 with 430,056 shares traded as of 10:41 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

5 Technical Setups to Recoup June Losses

5 Technical Setups to Recoup June Losses

Even though the market's been shoved significantly lower in June, there are still significant opportunities this month.

Quest Diagnostics' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Quest Diagnostics' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Celera Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition By Quest Diagnostics

Celera Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition By Quest Diagnostics

Celera Corporation (NASDAQ:CRA) today announced that Celera and other named defendants have today entered into a memorandum of understanding (MOU) with plaintiffs’ counsel in connection with the previously ...

Quest Stock To Go Ex-dividend Tomorrow (DGX)

Quest Stock To Go Ex-dividend Tomorrow (DGX)

The ex-dividend date for Quest Diagnostics (NYSE:DGX) is tomorrow, April one, 2011. Owners of shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $57.21 as of 9:30 a.m., the dividend yield is 0.7%.

10 Stocks to Watch: Celera, Quest, Nike

10 Stocks to Watch: Celera, Quest, Nike

Celera was popping in premarket trading after receiving an offer from diagnostics testing company Quest Diagnostics.

Quest to Buy Celera for $344 Million

Quest to Buy Celera for $344 Million

Quest Diagnostics agreed to acquire Celera for $8 a share, or $344 million.

Time Warner, Hershey: Premarket Trading

Time Warner, Hershey: Premarket Trading

Hershey Foods said fourth-quarter net income grew about 7%.

GlaxoSmithKline Sells Quest Stake for $1.7B

GlaxoSmithKline Sells Quest Stake for $1.7B

GlaxoSmithKline said Wednesday it sold its entire stake in Quest Diagnostics for $1.7 billion.

Intel, BP, Altera: Analysts' New Ratings

Intel, BP, Altera: Analysts' New Ratings

Intel upgraded at BMO from Market Perform to Outperform. Valuation call. $27 price target.

Quest Diagnostics CEO Discusses Q4 2010 Earnings Call Transcript

Quest Diagnostics CEO Discusses Q4 2010 Earnings Call Transcript

Quest Diagnostics CEO Discusses Q4 2010 Earnings Call Transcript

Trading Rules in the Quest for Profits

Trading Rules in the Quest for Profits

We are going to use options on Quest Diagnostics to walk through my basics for trading and devise a strategy to maximize profits on the position.

TheStreet Quant Rating: B+ (Buy)